The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Safety and Immunogenicity of Varicella-Zoster Virus Vaccine in Pediatric Liver and Intestine Transplant Recipients
Open accessAbstract
Primary varicella-zoster virus (VZV) infections following organ transplantation may cause significant morbidity. We examined the safety and immunogenicity of Varivax after transplantation as a potential prophylactic tool. Pediatric liver and intestine transplant recipients without history of chickenpox received one dose of Varivax. VZV humoral and cellular immunity were assessed before and > or =12 weeks after vaccination. Adverse events (AE) and management of exposure to wild type VZV were monitored. Sixteen VZV-naïve subjects, 13-76 months of age, at 257-2045 days after transplantation were immunized. Five children developed mild local AE of short duration. Four subjects developed fever and four developed non-injection site rashes, three of whom received acyclovir. Liver enzymes did not increase during the month after vaccination. Eighty-seven percent and 86% of children developed humoral and cellular immunity, respectively. There were five reported exposures to varicella in four children, none of which resulted in chickenpox. One subject received VZV-immunoglobulin and another subject with liver enzyme elevations after exposure received acyclovir; all remained asymptomatic. Varivax was safe and immunogenic in pediatric liver and intestine transplant recipients. Larger studies are needed to establish the efficacy and role of varicella vaccination after transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Self-citation
Cited by
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Self-citationDanziger‐Isakov, L., Kumar, D., & Practice, T. A. I. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13563 · Cited by 492
Guidelines for Vaccination of Solid Organ Transplant Candidates and Recipients
Danzinger-Isakov, L., & Kumar, D. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02917.x · Cited by 271
Vaccination in Solid Organ Transplantation
Danziger-Isakov, L., & Kumar, D. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12122 · Cited by 264
Metadata
- Authors
- Weinberg, A., Horslen, S. P., Kaufman, S. S., Jesser, R., DeVoll-Zabrocki, A., Fleckten, B. L., Kochanowicz, S., Seipel, K. R., & Levin, M. J.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 6
- Issue
- 3
- Pages
- 565-568
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2018179598
- Cited by
- 158
- References
- 1
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and Immunogenicity of Varicella-Zoster Virus Vaccine in Pediatric Liver and Intestine Transplant Recipients. https://app.cochat.ai/papers/10.1111/j.1600-6143.2005.01210.x
- The paper
- Weinberg, A., Horslen, S. P., Kaufman, S. S., Jesser, R., DeVoll-Zabrocki, A., Fleckten, B. L., Kochanowicz, S., Seipel, K. R., & Levin, M. J. (2006). Safety and Immunogenicity of Varicella-Zoster Virus Vaccine in Pediatric Liver and Intestine Transplant Recipients. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2005.01210.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.